South Dakota Investment Council’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,057
| Closed | -$766K | – | 604 |
|
|
2021
Q1 | $766K | Buy |
8,057
+71
| +0.9% | +$6.75K | 0.01% | 507 |
|
|
2020
Q4 | $495K | Hold |
7,986
| – | – | 0.01% | 520 |
|
|
2020
Q3 | $475K | Hold |
7,986
| – | – | 0.01% | 503 |
|
|
2020
Q2 | $557K | Hold |
7,986
| – | – | 0.01% | 475 |
|
|
2020
Q1 | $362K | Hold |
7,986
| – | – | 0.01% | 480 |
|
|
2019
Q4 | $520K | Sell |
7,986
-831
| -9% | -$54.1K | 0.01% | 490 |
|
|
2019
Q3 | $547K | Hold |
8,817
| – | – | 0.01% | 516 |
|
|
2019
Q2 | $628K | Hold |
8,817
| – | – | 0.01% | 485 |
|
|
2019
Q1 | $691K | Buy |
8,817
+1,764
| +25% | +$138K | 0.01% | 469 |
|
|
2018
Q4 | $597K | Buy |
7,053
+2,725
| +63% | +$231K | 0.02% | 451 |
|
|
2018
Q3 | $741K | Buy |
+4,328
| New | +$741K | 0.02% | 456 |
|